$90.94
1.611.80%
At Close: -
$90.94
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Blueprint Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Blueprint Medicines using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.80 | $-1.29 | 38.0 % |
Mar 2024 | 2024-05-02 | $-1.32 | $-1.66 | 20.5 % |
Dec 2023 | 2024-02-15 | $-1.82 | $-2.04 | 10.8 % |
Sep 2023 | 2023-10-26 | $-2.20 | $-2.37 | 7.17 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $138.16M | $103.00M | 34.1 % |
Mar 2024 | 2024-05-02 | $96.12M | $80.43M | 19.5 % |
Dec 2023 | 2024-02-15 | $71.96M | $66.64M | 7.98 % |
Sep 2023 | 2023-10-26 | $56.57M | $50.40M | 12.2 % |
Blueprint Medicines (BPMC) is scheduled to report earnings on October 24, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.80, which beat the estimate of $-1.29.
The Actual Revenue was $138.2M, which beat the estimate of $103M.
Browse earnings estimates, EPS, and revenue on all stocks.